Bindinglaw

US · guidance

NCD 30.8

Cellular Therapy

activein force · 1966-01-01 – presentact-effective-date

Item/Service Description

Cellular therapy involves the practice of injecting humans with foreign proteins like the placenta or lungs of unborn lambs. Cellular therapy is without scientific or statistical evidence to document its therapeutic efficacy and, in fact, is considered a potentially dangerous practice.

Indications and Limitations of Coverage

Accordingly, cellular therapy is not considered reasonable and necessary within the meaning of section 1862(a)(1) of the Act.

History

Version 1

Provenance

Source
cms.gov
Retrieved
2026-08-26
Edition
mcd-2026-08-26
Content hash
7be3004fed0457dcb83d3f26f44d5795a3557998ea6d1532204977db4ae0017b
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.
NCD 30.8 — Cellular Therapy · binding.law